Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Masahiko Tozawa"'
Autor:
Masahiko Tozawa, Shuichi Takishita, Chiho Iseki, Kunitoshi Iseki, Kentaro Kohagura, Kozen Kinjo, Kaori Tokashiki
Publikováno v:
Clinical and Experimental Nephrology. 13:55-60
Obesity and metabolic syndrome are risk factors for the development of chronic kidney disease (CKD). Few studies have examined the effect of change in body mass index (DeltaBMI) on CKD incidence in a general screening setting.Subjects of this study w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f8bc0c0f7774f2cc92996ffa103b707
https://doi.org/10.1007/s10157-008-0085-y
https://doi.org/10.1007/s10157-008-0085-y
Autor:
Shuichi Takishita, Masahiko Tozawa, Kunitoshi Iseki, Yoshiharu Ikemiya, Chiho Iseki, Kozen Kinjo
Publikováno v:
Clinical and Experimental Nephrology. 9:46-52
Disturbances in lipid metabolism are often observed in patients with renal failure and could be a risk factor for end-stage renal disease (ESRD). However, few studies have examined abnormal lipid metabolism as a risk factor for the development of ESR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::723fdf34661104720271ee1da0ff6ac8
https://doi.org/10.1007/s10157-004-0332-9
https://doi.org/10.1007/s10157-004-0332-9
Publikováno v:
Clinical and Experimental Nephrology. 7:231-237
The Determinants of the prescribed dialysis dose have not been well studied in a large patient population. Few studies have examined survival rates after adjusting for dose determinants.Data were obtained from a cohort of chronic hemodialysis patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e3f371252b0074c5c854690dc11cb08
https://doi.org/10.1007/s10157-003-0242-2
https://doi.org/10.1007/s10157-003-0242-2
Autor:
Shuichi Takishita, Chiho Iseki, Kozen Kinjo, Yoshiharu Ikemiya, Kunitoshi Iseki, Masahiko Tozawa
Publikováno v:
Hypertension. 41:1341-1345
Blood pressure as a risk factor for development of end-stage renal disease has not been fully studied, particularly in women. We studied the development of end-stage renal disease from 1983 through 2000 in 98 759 subjects, 46 881 men and 51 878 women
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eddd7a10f88e32b54c2b5f5753114494
https://doi.org/10.1161/01.hyp.0000069699.92349.8c
https://doi.org/10.1161/01.hyp.0000069699.92349.8c
Publikováno v:
Nephrology Dialysis Transplantation. 18:782-787
Background. Atherosclerosis and vascular calcification are common in chronic haemodialysis (HD) patients, and usually progress with time. Whether the length of dialysis treatment in chronic HD patients is a significant independent risk factor of deat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b04859aa2c5d5a7691cc6342f5dcea3
https://doi.org/10.1093/ndt/gfg145
https://doi.org/10.1093/ndt/gfg145
Autor:
Kunitoshi Iseki, Masahiko Tozawa, Yasushi Higashiuesato, Chiho Iseki, Takeshi Tana, Saori Oshiro, Masanobu Yamazato, Shuichi Takishita, Nozomi Tomiyama, Yoshiharu Ikemiya
Publikováno v:
Kidney International. 62:2195-2201
Evidence for elevated pulse pressure in patients on chronic hemodialysis: A case-control study.BackgroundFew analyses have compared pulse pressure (PP) values in hemodialysis patients with healthy individuals, and they have provided only limited data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e49463e170fe9d5fb856788304df61f
https://doi.org/10.1046/j.1523-1755.2002.00665.x
https://doi.org/10.1046/j.1523-1755.2002.00665.x
Autor:
Yoshiharu Ikemiya, Kunitoshi Iseki, Chiho Iseki, Shuichi Takishita, Masahiko Tozawa, Saori Oshiro
Publikováno v:
Kidney International. 62(5):1743-1749
Triglyceride, but not total cholesterol or low-density lipoprotein cholesterol levels, predict development of proteinuria. Background Epidemiological data about the relationship between dyslipidemia and proteinuria are sparse. We conducted a retrospe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d42a9297ff780da9faebfcb4579a9800
Autor:
Masahiko Tozawa, Saori Oshiro, Kunitoshi Iseki, Shuichi Takishita, Takeshi Tana, Chiho Iseki, Nozomi Tomiyama, Yasushi Higashiuesato, Masanobu Yamazato
Publikováno v:
Nephrology Dialysis Transplantation. 17:1819-1824
Background. Information concerning medication use in Asian haemodialysis patients is sparse. We surveyed prescribed medications and examined the relation between the number of medications and mortality and clinical characteristics in chronic haemodia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3185c08929c365c111e2248c174efe2
https://doi.org/10.1093/ndt/17.10.1819
https://doi.org/10.1093/ndt/17.10.1819
Publikováno v:
Kidney International. 61:717-726
Pulse pressure and risk of total mortality and cardiovascular events in patients on chronic hemodialysis. Background Pulse pressure (PP) has been shown as a risk factor for mortality or cardiovascular events in several studies. However, the impact of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e88e18100d4890b9ded8ed6867871dd2
https://doi.org/10.1046/j.1523-1755.2002.00173.x
https://doi.org/10.1046/j.1523-1755.2002.00173.x
Autor:
Kunitoshi Iseki, Saori Oshiro, Shuichi Takishita, Koshiro Fukiyama, Yoshiharu Ikemiya, Masahiko Tozawa
Publikováno v:
Hypertension Research. 25:185-190
The incidence of end-stage renal disease due to diabetes mellitus (DM) is increasing. There have been too few epidemiological studies of the predictors of DM nephropathy, particularly type 2 DM, among a statistically significant population. We studie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78a61436e6765eb38f2046a8df010389
https://doi.org/10.1291/hypres.25.185
https://doi.org/10.1291/hypres.25.185